@FierceMedDev: ICYM this week's M&A feature - Blockbusters and bloodlettings: A look at 2013's hot start. Special report | Follow @FierceMedDev
@MarkHFierce: Only a few weeks left to nominate a company for this year's FMD Fierce 15. Submit your nomination | Follow @MarkHFierce
@DamianFierce: Device outfit CVRx has raised $29.6M in a round led by NEA and J&J. Article | Follow @DamianFierce
> Maryland's iSonea raised $13.5 million to market AirSonea, a personal monitoring device that detects airway obstruction in asthma. Release
> NeuroMetrix ($NURO) enjoyed a big bump in its stock price after gaining 510(k) clearance to use its pain-management device during sleep on diabetic patients. Story
> The FDA has assigned its most serious Class I recall label to Verathon's GlideScope Video Laryngoscope, warning that the device's reusable blades can break off and damage patients' airways. More
> California startup SynGen raised $2 million in financing to help advance development of a stem cell harvesting device. Story
> St. Jude Medical's ($STJ) Accent MRI pacemaker, launched recently in Japan, should help the company regain lost market share in the global cardiac rhythm management space, some speculate. Item
> Quest Diagnostics ($DGX) has teamed up with the Centers for Disease Control and Prevention (CDC) to promote hepatitis C screening. News
> Devicemaker Minnetronix has acquired Neurofluidics, a neurocritical care technology specialist. Release
> PathoQuest attracted $5 million in a series B private equity round--money that will help continue development of its diagnostic that relies on next-generation sequencing and cloud-based analysis software. Story (reg. req.)
Biotech News
@FierceBiotech: 2013 Biotech IPOs: The biotech IPO scene turns red hot. Special report | Follow @FierceBiotech
@JohnCFierce: Deborah Dunsire makes quick leap from Millennium to fast-growing EnVivo. News | Follow @JohnCFierce
@RyanMFierce: Alnylam Pharma spotlights more upbeat human data for gene-silencing drugs. Story | Follow @RyanMFierce
@EmilyMFierce: Antileukemia compound could also treat common breast cancers. Story | Follow @EmilyMFierce
> Rockwell Medical shares spike on positive PhIII data. Item
> EU, pharma industry pledge $4.4B for R&D projects. Story
> Booming China poised to take a top position in global drug R&D. Article
Pharma News
@FiercePharma: Pharma, FDA still lag in postmarketing safety studies. Getting better, but large % unfinished--or not begun. Yesterday's story | Follow @FiercePharma
@CarlyHFierce: NICE says 'no' to Celgene's Revlimid. Article | Follow @CarlyHFierce
> New problems for GSK in China as authorities say GSK employees confess to bribery. News
> Vivus hooks up with Menarini to hawk ED pill Spedra in $121M deal. More
Pharma Manufacturing News
@EricPFierce: BioPlan says China, India losing luster for outsourced biopharmaceutical manufacturing. More | Follow @EricPFierce
> Wockhardt faces 2nd import alert. Report
> Sanofi's ImmuCyst available in next year, Alliance Pharma says. More
> Pfizer to invest $130M in 2 plants in Ireland. News
> Contract manufacturer Piramal also into development, cellphones. Story
Vaccines News
> Manufacturers prepare for resurgence of H7N9. News
> Robot eases kids' vaccination distress in study. More
> Novartis inks typhoid vax licensing deal with Biological E. Story
> U.K. mumps outbreak linked to waning MMR protection. Report
